In this article, we take a look at eight biotechs advancing their monoclonal antibodies through the clinic that have made the ...

The experimental monoclonal antibody drug acts like a shield to protect insulin-producing cells from damage, even extending ...

Johns Hopkins researchers have shown that a monoclonal antibody can reverse type 1 diabetes. It targets a different antigen ...

A $4.9 billion hole has appeared in Gilead’s pipeline. After years of setbacks, the big biotech dealt a final blow to its ...

A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and ...

Researchers at the Indian Institute of Science (IISc) have designed a synthetic compound (antigen) that can latch on to a ...

CVS is getting into the business of making copycat biologic drugs, known as biosimilars, to profit directly from blockbusters ...

StarBright Dyes are compatible with most experimental protocols and flow cytometers, including the Bio-Rad ZE5 Cell Analyzer, ...

Allied Market Research published a report, titled, “Antibody Production Market by Product (Instruments, Consumables), Process (Upstream Processing, Downstream Processing), and End User (Pharmaceutical ...

A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by ...

A new study reports a single dose of a malaria antibody was 77% effective in protecting children in Mali from malaria, ...

Antibody-drug conjugate (ADC) is a promising class of cancer treatments with accelerating U.S. Food and Drug Administration (FDA) approval and rapidly growing market size as discussed in previous ...